[Polaris Group] March 2026 Revenue NT$2M (YoY -59.7%)
Biopharmaceutical company Polaris Group (code: 6550) reported monthly revenue of NT$1.57 million for March 2026, a 59.7% decrease year-on-year, likely reflecting the progress of clinical trials and the pre-product launch stage.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 13, 2026 at 10:56 (18h 26m after Collected)
Company Code: 6550
Company Name: Polaris Group
Industry: Biotechnology and Medical Care
Data Month: 2026-03
Monthly Revenue: 1,578 thousand NTD (1.58 million)
Year-on-Year Change: -59.7%
Company Name: Polaris Group
Industry: Biotechnology and Medical Care
Data Month: 2026-03
Monthly Revenue: 1,578 thousand NTD (1.58 million)
Year-on-Year Change: -59.7%
FAQ
What was Polaris Group's revenue for March 2026?
Polaris Group's revenue for March 2026 was 1,578 thousand NTD, which is equivalent to 1.58 million NTD.
How did Polaris Group's March 2026 revenue compare to the previous year?
Polaris Group's revenue in March 2026 experienced a significant year-on-year decrease of 59.7%.
What is the company code for Polaris Group?
The company code for Polaris Group is 6550.
In which industry sector does Polaris Group operate?
Polaris Group operates within the Biotechnology and Medical Care industry sector.
What was the specific month and year for the reported revenue data?
The reported revenue data for Polaris Group pertains to the month of March in the year 2026.